PROXEON BIOSYSTEMS ApS: Financial statements 2025
CVR: 26848024
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity in the 2025 report amounted to DKK 386,590,000. The solvency ratio was 99.8%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 2,950,000
- Equity
- DKK 386,590,000
- Total Assets
- DKK 387,551,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 3 mio. | 386.6 mio. | 0 |
| 2024 | - | 0 | 3.7 mio. | 383.6 mio. | - |
| 2023 | - | 36.9 mio. | -7.4 mio. | 379.9 mio. | - |
| 2022 | - | 39.4 mio. | 30.4 mio. | 387.4 mio. | - |
| 2021 | - | 30.9 mio. | 23.9 mio. | 357 mio. | - |
How creditworthy is PROXEON BIOSYSTEMS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PROXEON BIOSYSTEMS ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 3,703,000.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The board consists of Piet Van der Zande (chair), Anthony Hugh Smith and Simon Lie. The company is owned by NUNC A/S. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity in the 2025 report amounted to DKK 386,590,000.